Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE009 (AUS) (Dr. Novak)
· consented 2022-09-23
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-10-24 (study day 13); relationship: N
mild
assessed
2026-08-18
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-11-11 (study day 31); relationship: N
severe
assessed
2026-08-18
Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-01-10 (study day 91); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.